CSIMarket
 
Mangoceuticals Inc   (NASDAQ: MGRX)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $4.5200 $0.10 2.262%
Day's High: $4.699 Week Perf: 32.16 %
Day's Low: $ 4.15 30 Day Perf: 73.85 %
Volume (M): 205 52 Wk High: $ 4.70
Volume (M$): $ 924 52 Wk Avg: $1.04
Open: $4.41 52 Wk Low: $0.14



 Market Capitalization (Millions $) 9
 Shares Outstanding (Millions) 2
 Employees 11
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Mangoceuticals Inc
Mangoceuticals Inc is a company that specializes in developing and marketing products derived from mangoes, known as mangoceuticals. They focus on harnessing the nutritional and therapeutic properties of mangoes to create innovative health and wellness solutions. Mangoceuticals Inc is committed to providing natural and sustainable products that promote overall well-being. They work closely with farmers and suppliers to ensure high-quality ingredients sourced from eco-friendly practices. The company aims to cater to customer needs through research, product development, and education on the benefits of mangoceuticals.


   Company Address: 15110 N. Dallas Parkway Dallas 75248 TX
   Company Phone Number: 242-9619   Stock Exchange / Ticker: NASDAQ MGRX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
HIMS        14.5% 
CLMT        5.45% 
LLY   -0.55%    
RNG        0.43% 
• View Complete Report
   



Mangoceuticals Inc

Mangoceuticals Inc. Sees Impressive 112.56% Surge in Revenue in First Quarter of 2024

Mangoceuticals Inc Experiences Positive Revenue Growth, But Reports Net Deficit for Q1 2024
Mangoceuticals Inc, a company operating in the Healthcare Facilities sector, has announced its financial results for the period ending March 31, 2024. The company reported a significant improvement in revenue, which saw a sharp increase of 112.56% to $0.21 million compared to $0.10 million in the same reporting season last year. However, there was a sequential decline of -12.39% from the previous reporting period's revenue of $0.24 million.
Mangoceuticals Inc's positive revenue growth in the first quarter of 2024 aligns with its peers in the Healthcare Facilities sector, which experienced an overall top-line elevation of 8.77% during the same period. This trend indicates that Mangoceuticals Inc is performing well within its industry.







Mangoceuticals Inc's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com